LIMN
LIMN
NASDAQ · Biotechnology

Liminatus Pharma Inc-Cl A

$0.17
0.00 (-0.52%)
As of Apr 1, 10:10 PM ET ·
Financial Highlights (FY 2025)
Revenue
7.61M
Net Income
881.2K
Gross Margin
39.4%
Profit Margin
11.6%
Rev Growth
-2.4%
D/E Ratio
0.23
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 39.4% 39.4% 39.4%
Operating Margin 14.2% 13.3% 12.6%
Profit Margin 11.6% 12.5% 13.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 7.61M 6.76M 8.11M
Gross Profit 3.00M 2.66M 3.19M
Operating Income 1.08M 901.7K 1.02M
Net Income 881.2K 841.9K 1.08M
Gross Margin 39.4% 39.4% 39.4%
Operating Margin 14.2% 13.3% 12.6%
Profit Margin 11.6% 12.5% 13.3%
Rev Growth -2.4% +10.1% +12.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 5.12M 4.73M 4.09M
Total Equity 22.23M 21.00M 21.13M
D/E Ratio 0.23 0.23 0.19
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.17M 1.13M 1.25M
Free Cash Flow 539.3K 438.1K 671.3K